Patent · US Active

Anti-human OX40L antibodies and methods of treatment

US9139653B1 · kind B1 · utility

31Cited by
11References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2015
Grant dateSep 22, 2015
Priority date
Expiry dateApr 30, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to anti-human OX40L antibodies, new medical uses and methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.